Notably, previous studies have demonstrated strong interactions between certain TKIs and ABCB1 and/or ABCG2, resulting in the resensitization of multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2 [35,36,51,52]. Here, ABCG2 is linked to cancer.